Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
The Korean Journal of Internal Medicine|April 6, 2016
Chronic lymphocytic leukemia: a clinical review including Korean cohortsYoung-Woo Jeon, Seok-Goo ChoClinical Nuclear Medicine|February 2, 2024
Cerebrovascular Malformation Mimicking Recurrent Lymphoma on Dual Time-Point 18F-FDOPA PETSonya Youngju Park, Min Kyoung Lee, Eun Ji Han, et al.ACS Applied Materials & Interfaces|October 29, 2025
Collective Mechanical Memory Encoded by Long-Lasting Supracellular Cytoskeletal Structures in Multicellular SpheroidsJiwon Kim, Hyuntae Jeong, Young-Woo Jeon, et al.Transplantation and Cellular Therapy|October 6, 2022
Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 StudyYaeni Kim, Sung-Soo Park, Young-Woo Jeon, et al.Journal of Cancer Research and Clinical Oncology|July 7, 2023
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 studyJung Yeon Lee, Sung-Soo Park, Young-Woo Jeon, et al.Cancers|October 14, 2023
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)Sung-Soo Park, Seung-Hwan Shin, Jung-Yeon Lee, et al.Journal of Cancer Research and Clinical Oncology|September 12, 2023
Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203)Sung-Soo Park, Seo-Young Goo, Young-Woo Jeon, et al.Blood Research|October 18, 2014
Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumabJee Wan Wee, Young Woo Jeon, Jun Young Eun, et al.The Korean Journal of Internal Medicine|October 21, 2017
Third-party regulatory T cells prevent murine acute graft-versus-host diseaseJung-Yeon Lim, Keon-Il Im, Yunejin Song, et al.American Journal of Translational Research|April 12, 2019
Down-regulation of intracellular reactive oxygen species attenuates P-glycoprotein-associated chemoresistance in Epstein-Barr virus-positive NK/T-cell lymphomaYoung-Sun Nam, Keon-Il Im, Nayoun Kim, et al.Pageof 13